MED6 Antikörper (AA 27-246)
Kurzübersicht für MED6 Antikörper (AA 27-246) (ABIN7159164)
Target
Alle MED6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 27-246
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Mediator of RNA polymerase II transcription subunit 6 protein (27-246AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:200-1:1000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MED6 (Mediator Complex Subunit 6 (MED6))
-
Andere Bezeichnung
- MED6
-
Hintergrund
-
Background: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
Aliases: Activator recruited cofactor 33 kDa antibody, Activator-recruited cofactor 33 kDa component antibody, ARC33 antibody, hMed6 antibody, MED6 antibody, MED6_HUMAN antibody, Mediator complex subunit 6 antibody, Mediator of RNA polymerase II transcription subunit 6 antibody, NY REN 28 antibody, NY REN 28 antigen antibody, Renal carcinoma antigen NY-REN-28 antibody, RNA polymerase transcriptional regulation mediator subunit 6 antibody
-
UniProt
- O75586
-
Pathways
- Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
Target
-